509 related articles for article (PubMed ID: 33183883)
1. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics.
Staudacher HM; Scholz M; Lomer MC; Ralph FS; Irving PM; Lindsay JO; Fava F; Tuohy K; Whelan K
Clin Nutr; 2021 Apr; 40(4):1861-1870. PubMed ID: 33183883
[TBL] [Abstract][Full Text] [Related]
2. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
[TBL] [Abstract][Full Text] [Related]
3. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
Staudacher HM; Whelan K
Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
Ankersen DV; Weimers P; Bennedsen M; Haaber AB; Fjordside EL; Beber ME; Lieven C; Saboori S; Vad N; Rannem T; Marker D; Paridaens K; Frahm S; Jensen L; Rosager Hansen M; Burisch J; Munkholm P
J Med Internet Res; 2021 Dec; 23(12):e30291. PubMed ID: 34904950
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet.
Valdez-Palomares F; Nambo-Venegas R; Uribe-García J; Mendoza-Vargas A; Granados-Portillo O; Meraz-Cruz N; Palacios-González B
Food Funct; 2021 Apr; 12(7):3206-3218. PubMed ID: 33877245
[TBL] [Abstract][Full Text] [Related]
6. Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome.
Rossi M; Aggio R; Staudacher HM; Lomer MC; Lindsay JO; Irving P; Probert C; Whelan K
Clin Gastroenterol Hepatol; 2018 Mar; 16(3):385-391.e1. PubMed ID: 28993261
[TBL] [Abstract][Full Text] [Related]
7. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
[TBL] [Abstract][Full Text] [Related]
8. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
[TBL] [Abstract][Full Text] [Related]
9. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
[TBL] [Abstract][Full Text] [Related]
10. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?
Ooi SL; Correa D; Pak SC
Complement Ther Med; 2019 Apr; 43():73-80. PubMed ID: 30935559
[TBL] [Abstract][Full Text] [Related]
11. Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome.
Wilson B; Kanno T; Slater R; Rossi M; Irving PM; Lomer MC; Probert C; Mason AJ; Whelan K
Aliment Pharmacol Ther; 2023 Aug; 58(4):404-416. PubMed ID: 37313992
[TBL] [Abstract][Full Text] [Related]
12. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
Chumpitazi BP; Cope JL; Hollister EB; Tsai CM; McMeans AR; Luna RA; Versalovic J; Shulman RJ
Aliment Pharmacol Ther; 2015 Aug; 42(4):418-27. PubMed ID: 26104013
[TBL] [Abstract][Full Text] [Related]
13. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.
Staudacher HM; Ralph FSE; Irving PM; Whelan K; Lomer MCE
J Acad Nutr Diet; 2020 Apr; 120(4):535-547. PubMed ID: 31029650
[TBL] [Abstract][Full Text] [Related]
14. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.
Pedersen N; Andersen NN; Végh Z; Jensen L; Ankersen DV; Felding M; Simonsen MH; Burisch J; Munkholm P
World J Gastroenterol; 2014 Nov; 20(43):16215-26. PubMed ID: 25473176
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
16. The impact of diet and ethnicity on gut microbiota variation in irritable bowel syndrome: A multi-center study.
Khoo XH; Chong CW; Talha AM; Philip K; Teh CS; Isa AM; Wong MS; Chew DC; Wong Z; Jusoh NS; Maksum NMM; Mokhtar NM; Majid HA; Ali RAR; Lee YY; Mahadeva S
J Gastroenterol Hepatol; 2023 Aug; 38(8):1259-1268. PubMed ID: 36908030
[TBL] [Abstract][Full Text] [Related]
17. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome.
Naseri K; Dabiri H; Rostami-Nejad M; Yadegar A; Houri H; Olfatifar M; Sadeghi A; Saadati S; Ciacci C; Iovino P; Zali MR
BMC Gastroenterol; 2021 Jul; 21(1):292. PubMed ID: 34261437
[TBL] [Abstract][Full Text] [Related]
18. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
19. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
Wilson B; Rossi M; Kanno T; Parkes GC; Anderson S; Mason AJ; Irving PM; Lomer MC; Whelan K
Am J Gastroenterol; 2020 Jun; 115(6):906-915. PubMed ID: 32433273
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
Francavilla R; Piccolo M; Francavilla A; Polimeno L; Semeraro F; Cristofori F; Castellaneta S; Barone M; Indrio F; Gobbetti M; De Angelis M
J Clin Gastroenterol; 2019 Mar; 53(3):e117-e125. PubMed ID: 29688915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
